Jim Bush
Washington Department of Fish and Wildlife(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Dermatologic Treatments and Research, Wound Healing and Treatments, COVID-19 Clinical Research Studies, Diabetes Treatment and Management
Most-Cited Works
- → Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2(2021)394 cited
- → Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring(2011)79 cited
- → Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2(2021)52 cited
- → Randomized phase II clinical trial of avotermin versus placebo for scar improvement(2011)47 cited
- → Dietary fat supplementation effects on in vitro nutrient disappearance and in vivo nutrient intake and total tract digestibility by horses.(2001)45 cited
- → Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects(2016)35 cited
- → Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial(2021)29 cited
- → Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential(2018)29 cited
- → Remote Wound Monitoring of Chronic Ulcers(2010)28 cited
- → Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2(2020)24 cited